Literature DB >> 9112488

Open surgical exploration after failed endopyelotomy: a 12-year perspective.

M Gupta1, O L Tuncay, A D Smith.   

Abstract

PURPOSE: Factors that have a role in endopyelotomy failure have not been fully elucidated but are believed to include high grade hydronephrosis and the presence of crossing vessels at the ureteropelvic junction.
MATERIALS AND METHODS: We retrospectively analyzed the importance of renal function, hydronephrosis, ureteral stents, surgeon experience and crossing vessels in determining the outcome of endopyelotomy.
RESULTS: Of 401 percutaneous antegrade endopyelotomies performed at our medical center during the last 12 years 60 failed and 54 of these patients underwent surgical exploration. Patients with high grade hydronephrosis and poor initial renal function were much less likely to have successful endopyelotomy than those with moderate hydronephrosis or good renal function (success rates 50 versus 96 and 54 versus 92%, respectively, p <0.001). The most common findings at exploration included severe extrinsic fibrosis and intrinsic fibrotic stenosis. Obstructing crossing vessels were present in 13 patients explored, suggesting a possible role in causing failure in only 4% of all endopyelotomy patients.
CONCLUSIONS: Patients with high grade hydronephrosis and poor initial renal function are much more likely to experience endopyelotomy failure. Crossing vessels appear to have a less significant role in endopyelotomy failure than has been previously suggested.

Entities:  

Mesh:

Year:  1997        PMID: 9112488

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Endopyelotomy in the age of laparoscopic and robotic-assisted pyeloplasty.

Authors:  Daniel Yong; David M Albala
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

Review 2.  Antegrade percutaneous endopyelotomy.

Authors:  Raymond Ko; Mordechai Duvdevani; John D Denstedt
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

Review 3.  Comparison of surgical approaches to ureteropelvic junction obstruction: endopyeloplasty versus endopyelotomy versus laparoscopic pyeloplasty.

Authors:  Robert J Stein; Inderbir S Gill; Mihir M Desai
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

Review 4.  Pathophysiology and treatment of ureteropelvic junction obstruction.

Authors:  Brent Williams; Basir Tareen; Martin I Resnick
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

5.  Endopyelotomy still has an important role in the management of ureteropelvic junction obstruction.

Authors:  Dinesh Samarasekera; Ben H Chew
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

6.  Laparoscopic pyeloplasty: the standard of care for ureteropelvic junction obstruction.

Authors:  Anil Kapoor; Christopher B Allard
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

7.  Endopyelotomy - a Minimally Invasive Surgical Option for Pelvi-ureteric Junction Obstruction: a Study Of 34 Cases.

Authors:  A A Pradhan; Rajeev Sood; P Madhusoodanan; A S Sandhu; S K Gupta; Anil Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Retroperitoneoscopic Anderson-Hynes dismembered pyeloplasty in infants and children: a 60-case report.

Authors:  Huixia Zhou; Hongzhao Li; Xu Zhang; Xin Ma; Hua Xu; Taoping Shi; Baojun Wang; Guoxi Zhang; Zhenghua Ju; Chao Wang; Jun Li; Zhun Wu
Journal:  Pediatr Surg Int       Date:  2009-05-07       Impact factor: 1.827

9.  Ureteroscopic management of upper tract transitional cell carcinoma and ureteropelvic obstruction.

Authors:  Sebastien Crouzet; Andre Berger; Manoj Monga; Mihir Desai
Journal:  Indian J Urol       Date:  2008-10

10.  Minimally invasive surgical options for ureteropelvic junction obstruction: A significant step in the right direction.

Authors:  Stephanie J Symons; Victor Palit; Chandra Shekhar Biyani; Jon J Cartledge; Anthony J Browning; Adrian D Joyce
Journal:  Indian J Urol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.